Shay Capital LLC Adma Biologics, Inc. Transaction History

Shay Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $33,610 - $51,708	-23,504 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $7,552 - $10,797	-5,900 Reduced 20.07%	23,504 $43,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $32,050 - $48,810	29,404 New	29,404 $41,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $180,363 - $263,363	-159,614 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.51 - $2.07 $58,817 - $80,630	38,952 Added 32.28%	159,614 $255,000
Q1 2021 Aug 13, 2021	BUY	$1.67 - $2.95 $118,005 - $208,452	70,662 Added 141.32%	120,662 $212,000
Q4 2020 Aug 13, 2021	BUY	$1.8 - $2.56 $90,000 - $128,000	50,000 New	50,000 $98,000

314

187M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.22B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.